XRTX XORTX Therapeutics Inc

Watchlist for October 9th 25 likes and I reveal my top 1. Also dont forget to follow $XRTX $SAIQ $VEEA $XELB What is your top pick?

$XRTX 🔺 maybe youll get out before the rug to 1.85 .. the. To .80 next.. 25% full port load at 2.40 🩸🩸🩸🩸🩸🩸 The FiB 🔺 $TSLA $SPY $BTC.X $DJT

$XRTX 😈🔺⌛. This will be your final warning... All the credit you maxed out to do this was point less . Worthless waist of time .. you will be Liquidated on that too.... Tick tock🩸🩸🩸🩸 The FiB 🔺 $TSLA $SPY $BTC.X $DJT

$XRTX some on this XORTX Outlines Anticipated Health Canada Clinical Trial Application for XRx-026 for Gout

$XRTX Looks more like a "we intend " rather than a "we have done " PR which suggests an offering is on the way to raise cash?. Absolutely nothing concrete in that press release that justifies any immediate price hike 🤷‍♂️

$XRTX I expect an outstanding performance today—good news is coming; those who were going to drop out have already dropped out.

$XRTX yesterday AH news, going again! XORTX Outlines Anticipated Health Canada Clinical Trial Application for XRx-026 for Gout

$XRTX reminds me of $ATYR. On Sept. 24, 2026, at 6 AM, it went from $0.37 to $0.73 premarket on news. By the open that same day, the entire move was gone. Now it’s crawling toward $0.20 and probably below, next catalyst probably in 2027, if at all. Not selling $ATYR at $0.60 was a mistake that may have cost me a few thousand euros. GL.

$XRTX Nice move check out $CATX $237 million cash and $109 million of real estate and a drug going into phase 3

$XRTX Even before the RS this stock could never stay over $2.20. Weak hands/scalpers over $2.20. History repeats..

$XRTX this market is so dead right now. Everything that has a green candle is immediately sold off or heavily shorted.

$XRTX always play short on trash stocks like this. 🐻 Look past the after-hours pop at the numbers: • Market cap about $3.3M with only 2 employees listed • Under $1M in cash and short-term investments as of 6/30/26 • Burned about $3.8M in operating cash in the first half of 2026 • Accumulated deficit over $15M, no revenue • Share count went from 1.39M to 1.73M in one quarter after a $5M stock sale, and is now about 1.79M • Did a 1-for-5 reverse split in April 2026 just to keep the Nasdaq listing • Filed a registration statement for a securities offering on Aug 14, 2026 • Gout drug IND was guided for H1 2026, now pushed to Q4 2026 • Signed a $2.5M paid IR/marketing deal, then postponed it until after their TSXV delisting, so promotion could come back • Down from a $7.05 52-week high Tiny float plus tiny cash balance plus an open shelf usually means more dilution. Not financial advice. Disclosure: I'm short XRTX.

$XRTX this is the next type of squeeze, like we squeezed $JAGX to 50$ plus, bulls in control tomorrow as US Market opens may skyrocket!!!

$XRTX XORTX Outlines Anticipated Health Canada Clinical Trial Application for XRx-026 for Gout

$XRTX imagine spamming the board because you're so scared your gone be broke by Premarket 😂😂😂😂

$XRTX watching it tomorrow for potential breakout, night everyone! See ya over 50$ here bulls in control next!!!

$XRTX 🐻 Look past the after-hours pop at the numbers: • Market cap about $3.3M with only 2 employees listed • Under $1M in cash and short-term investments as of 6/30/26 • Burned about $3.8M in operating cash in the first half of 2026 • Accumulated deficit over $15M, no revenue • Share count went from 1.39M to 1.73M in one quarter after a $5M stock sale, and is now about 1.79M • Did a 1-for-5 reverse split in April 2026 just to keep the Nasdaq listing • Filed a registration statement for a securities offering on Aug 14, 2026 • Gout drug IND was guided for H1 2026, now pushed to Q4 2026 • Signed a $2.5M paid IR/marketing deal, then postponed it until after their TSXV delisting, so promotion could come back • Down from a $7.05 52-week high Tiny float plus tiny cash balance plus an open shelf usually means more dilution. Not financial advice. Disclosure: I'm short XRTX.

$XRTX overnight never counts, just like it never counted in $JAGX $MRNA and many other biotechs, as biotech is the master killer for short sellers so for that reason XRTX may squeeze to 50$ next..... let's see...

$XRTX worth watching XORTX Therapeutics to file Clinical Trial Application with Health Canada for XRx-026 gout program to support future FDA NDA

$XRTX showing a bullish MACD cross on the daily, the kind of signal that tends to get overlooked by regular investors but not by the PRO TRADERS 🔥 like us who are watching closely. Worth keeping on your radar while it builds. 👀